ArticleInternational journal of colorectal disease2024

Subcutaneous infliximab in Crohn's disease patients with previous immunogenic failure of intravenous infliximab.

Julia Husman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.